AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Arcosa, Inc.

$145 +$38.21 (+35.78%)
NYSE · 11 Sep 2026 20:00 UTC
Previous Close
$145.25
Day Range
$145$145.6
Year Range
$89.03$146.92
Market Cap
7.12B
AVG Volume
642.79K
Trailing/Forward PE
14.5/29.79
PEG ratio
1.06
Dividend Yield
0.14%
Next Earnings Date
2026-10-29
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
01B2B3B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACA Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q22.74B
26 Q12.82B
25 Q42.88B
25 Q32.83B
25 Q22.68B
25 Q12.6B
24 Q42.57B
24 Q32.49B
24 Q22.44B
24 Q12.36B
Net Income (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACA Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2491.4M
26 Q1222.6M
25 Q4208.4M
25 Q3148.6M
25 Q292.2M
25 Q178.1M
24 Q493.7M
24 Q3128.5M
24 Q2147.4M
24 Q1142.7M
Operating Income (USD) · TTM
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACA Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2324.7M
26 Q1333.5M
25 Q4340.1M
25 Q3297.7M
25 Q2221.8M
25 Q1187.2M
24 Q4178M
24 Q3175.2M
24 Q2189.8M
24 Q1182.3M
EBITDA (USD) · TTM
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACA EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2606.6M
26 Q1564.1M
25 Q4573.1M
25 Q3542.1M
25 Q2451.8M
25 Q1408.6M
24 Q4395.9M
24 Q3374.1M
24 Q2384.2M
24 Q1366.1M
Cash Flows (USD) · TTM
0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACA Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2135.2M
26 Q1238.6M
25 Q4175.5M
25 Q3314.6M
25 Q2294.2M
25 Q1251.5M
24 Q4312.3M
24 Q3120.9M
24 Q216.3M
24 Q1100.7M
EPS (USD) · TTM
02.557.51024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACA EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q29.98
26 Q14.53
25 Q44.24
25 Q33.02
25 Q21.88
25 Q11.59
24 Q41.91
24 Q32.62
24 Q23.01
24 Q12.92
Expenses (USD) · TTM
0200M400M600MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACA Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q2531.4M
26 Q1484.3M
25 Q4472.7M
25 Q3472.6M
25 Q2467.6M
25 Q1493.9M
24 Q4509.7M
24 Q3492.7M
24 Q2485.1M
24 Q1481.2M
Shares Outstanding (USD) · TTM
-40M-20M020M40MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ACA Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q2-6.2M
26 Q12.9M
25 Q4-13.5M
25 Q3-12.6M
25 Q2-11M
25 Q1-13.4M
24 Q4-13.7M
24 Q30
24 Q2-900K
24 Q11.2M
Dividends (USD)
00.511.5Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26
ACA Dividends (USD) by quarter
PeriodDividends (USD)
Oct 260.05
Jul 260.05
Apr 260.05
Jan 260.05
Oct 250.05
Jul 250.05
Apr 250.05
Jan 250.05
Oct 240.05
Jul 240.05
Employee Count
02K4K6K8K20182019202020212022202320242025
ACA Employee Count by quarter
PeriodEmployee Count
20256.39K
20246.25K
20236.08K
20225.23K
20216.17K
20206.41K
20194.46K
20184.15K
PE Ratio
0204060med 37.64Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ACA PE Ratio by quarter
PeriodPE Ratio
Sep 2614.49
Sep 2614.53
Aug 2614.52
Aug 2614.48
Aug 2614.53
Aug 2614.47
Jul 2631.96
Jul 2631.92
Jul 2631.92
Jul 2631.92
Jul 2631.91
Jun 2631.81
Jun 2629.9
Jun 2628.51
Jun 2626.96
May 2627.9
May 2626.58
May 2627.33
May 2628.6
May 2627.46
Apr 2628.08
Apr 2626.92
Apr 2626.24
Apr 2625.32
Mar 2624.18
Mar 2623.67
Mar 2624.85
Mar 2625.74
Feb 2625.27
Feb 2641.65
Feb 2642.03
Feb 2641.13
Jan 2637.75
Jan 2637.43
Jan 2638.01
Jan 2636.74
Jan 2635.21
Dec 2536.36
Dec 2536.67
Dec 2536.55
Dec 2535.38
Nov 2535.13
Nov 2533.79
Nov 2533.13
Nov 2532.67
Oct 2533.63
Oct 2549.78
Oct 2549.45
Oct 2547.28
Oct 2548.97
Sep 2549.12
Sep 2550.77
Sep 2550.5
Sep 2551.79
Aug 2552.48
Aug 2552.68
Aug 2551.25
Aug 2550.87
Aug 2552.17
Jul 2556.83
Jul 2556.12
Jul 2555.95
Jul 2556.13
Jun 2554.88
Jun 2552.88
Jun 2553.52
Jun 2555.83
May 2553.79
May 2552.8
May 2555.49
May 2554.25
May 2543.71
Apr 2541.7
Apr 2540.22
Apr 2540.08
Apr 2537.62
Mar 2541.56
Mar 2541.4
Mar 2541.94
Mar 2541.36
Feb 2543.6
Feb 2535.23
Feb 2537.94
Feb 2538.54
Jan 2538.39
Jan 2537.99
Jan 2537.12
Jan 2534.98
Jan 2537.34
Dec 2437.34
Dec 2437.65
Dec 2441.36
Dec 2441.06
Nov 2441.17
Nov 2441.91
Nov 2438.43
Nov 2440.07
Nov 2435.51
Oct 2430.95
Oct 2431.3
Free Cash Flow Yield
0%2.5%5%7.5%10%med 5.11%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ACA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 261.9%
Sep 261.89%
Aug 261.9%
Aug 261.9%
Aug 261.89%
Aug 261.9%
Jul 263.35%
Jul 263.36%
Jul 263.36%
Jul 263.36%
Jul 263.36%
Jun 263.37%
Jun 263.58%
Jun 263.76%
Jun 263.98%
May 263.84%
May 264.03%
May 263.92%
May 263.75%
May 263.9%
Apr 263%
Apr 263.13%
Apr 263.21%
Apr 263.33%
Mar 263.48%
Mar 263.56%
Mar 263.39%
Mar 263.27%
Feb 263.33%
Feb 265.08%
Feb 265.04%
Feb 265.15%
Jan 265.61%
Jan 265.66%
Jan 265.57%
Jan 265.76%
Jan 266.01%
Dec 255.82%
Dec 255.77%
Dec 255.79%
Dec 255.98%
Nov 256.03%
Nov 256.27%
Nov 256.39%
Nov 256.48%
Oct 256.29%
Oct 256.41%
Oct 256.45%
Oct 256.75%
Oct 256.52%
Sep 256.5%
Sep 256.28%
Sep 256.32%
Sep 256.16%
Aug 256.08%
Aug 256.06%
Aug 256.23%
Aug 256.27%
Aug 256.17%
Jul 255.67%
Jul 255.74%
Jul 255.76%
Jul 255.74%
Jun 255.87%
Jun 256.09%
Jun 256.02%
Jun 255.77%
May 255.99%
May 256.1%
May 255.8%
May 255.94%
May 257.63%
Apr 257.99%
Apr 258.29%
Apr 258.32%
Apr 258.86%
Mar 258.02%
Mar 258.05%
Mar 257.95%
Mar 258.06%
Feb 257.65%
Feb 252.67%
Feb 252.48%
Feb 252.44%
Jan 252.45%
Jan 252.48%
Jan 252.53%
Jan 252.69%
Jan 252.52%
Dec 242.52%
Dec 242.5%
Dec 242.27%
Dec 242.29%
Nov 242.29%
Nov 242.25%
Nov 242.45%
Nov 242.35%
Nov 242.65%
Oct 240.36%
Oct 240.35%
Price to Sales
11.522.53med 1.86Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ACA Price to Sales by quarter
PeriodPrice to Sales
Sep 262.59
Sep 262.6
Aug 262.6
Aug 262.59
Aug 262.6
Aug 262.59
Jul 262.52
Jul 262.52
Jul 262.52
Jul 262.52
Jul 262.52
Jun 262.51
Jun 262.36
Jun 262.25
Jun 262.13
May 262.2
May 262.1
May 262.15
May 262.26
May 262.17
Apr 262.03
Apr 261.95
Apr 261.9
Apr 261.83
Mar 261.75
Mar 261.71
Mar 261.8
Mar 261.86
Feb 261.83
Feb 262.18
Feb 262.2
Feb 262.16
Jan 261.98
Jan 261.96
Jan 261.99
Jan 261.93
Jan 261.85
Dec 251.91
Dec 251.92
Dec 251.92
Dec 251.86
Nov 251.84
Nov 251.77
Nov 251.74
Nov 251.71
Oct 251.76
Oct 251.72
Oct 251.7
Oct 251.63
Oct 251.69
Sep 251.69
Sep 251.75
Sep 251.74
Sep 251.78
Aug 251.81
Aug 251.82
Aug 251.77
Aug 251.75
Aug 251.57
Jul 251.7
Jul 251.68
Jul 251.68
Jul 251.68
Jun 251.65
Jun 251.59
Jun 251.61
Jun 251.68
May 251.61
May 251.58
May 251.66
May 251.63
May 251.59
Apr 251.52
Apr 251.47
Apr 251.46
Apr 251.37
Mar 251.52
Mar 251.51
Mar 251.53
Mar 251.51
Feb 251.59
Feb 251.82
Feb 251.96
Feb 251.99
Jan 251.98
Jan 251.96
Jan 251.92
Jan 251.81
Jan 251.93
Dec 241.93
Dec 241.95
Dec 242.14
Dec 242.12
Nov 242.13
Nov 242.17
Nov 241.99
Nov 242.07
Nov 241.84
Oct 241.87
Oct 241.89
EV/EBITDA
10121416med 13.74Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ACA EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2613.41
Sep 2613.44
Aug 2613.43
Aug 2613.4
Aug 2613.44
Aug 2613.39
Jul 2615.04
Jul 2615.02
Jul 2615.02
Jul 2615.02
Jul 2615.02
Jun 2614.98
Jun 2614.22
Jun 2613.67
Jun 2613.06
May 2613.43
May 2612.91
May 2613.21
May 2613.71
May 2613.26
Apr 2612.49
Apr 2612.07
Apr 2611.82
Apr 2611.49
Mar 2611.08
Mar 2610.89
Mar 2611.32
Mar 2611.64
Feb 2611.47
Feb 2613.93
Feb 2614.04
Feb 2613.79
Jan 2612.86
Jan 2612.77
Jan 2612.93
Jan 2612.59
Jan 2612.17
Dec 2512.48
Dec 2512.57
Dec 2512.53
Dec 2512.21
Nov 2512.14
Nov 2511.78
Nov 2511.6
Nov 2511.47
Oct 2511.73
Oct 2513.6
Oct 2513.53
Oct 2513.09
Oct 2513.43
Sep 2513.46
Sep 2513.8
Sep 2513.74
Sep 2514.01
Aug 2514.15
Aug 2514.19
Aug 2513.9
Aug 2513.82
Aug 2513.84
Jul 2514.73
Jul 2514.59
Jul 2514.56
Jul 2514.6
Jun 2514.36
Jun 2513.97
Jun 2514.1
Jun 2514.54
May 2514.15
May 2513.96
May 2514.47
May 2514.24
May 2514.3
Apr 2513.82
Apr 2513.47
Apr 2513.44
Apr 2512.86
Mar 2513.79
Mar 2513.75
Mar 2513.88
Mar 2513.74
Feb 2514.27
Feb 2513.47
Feb 2514.4
Feb 2514.61
Jan 2514.56
Jan 2514.42
Jan 2514.12
Jan 2513.39
Jan 2514.2
Dec 2414.2
Dec 2414.31
Dec 2415.58
Dec 2415.48
Nov 2415.52
Nov 2415.77
Nov 2414.57
Nov 2415.14
Nov 2413.57
Oct 2413.54
Oct 2413.67
Price/Operating Cashflow
510152025med 13.11Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ACA Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2620.86
Sep 2620.92
Aug 2620.9
Aug 2620.85
Aug 2620.92
Aug 2620.84
Jul 2617.2
Jul 2617.17
Jul 2617.18
Jul 2617.17
Jul 2617.17
Jun 2617.12
Jun 2616.09
Jun 2615.34
Jun 2614.51
May 2615.01
May 2614.3
May 2614.7
May 2615.39
May 2614.78
Apr 2617.16
Apr 2616.45
Apr 2616.03
Apr 2615.47
Mar 2614.77
Mar 2614.46
Mar 2615.18
Mar 2615.73
Feb 2615.44
Feb 2613.19
Feb 2613.31
Feb 2613.02
Jan 2611.95
Jan 2611.85
Jan 2612.03
Jan 2611.63
Jan 2611.15
Dec 2511.51
Dec 2511.61
Dec 2511.57
Dec 2511.2
Nov 2511.12
Nov 2510.7
Nov 2510.49
Nov 2510.35
Oct 2510.65
Oct 2510.34
Oct 2510.28
Oct 259.83
Oct 2510.18
Sep 2510.21
Sep 2510.55
Sep 2510.49
Sep 2510.76
Aug 2510.91
Aug 2510.95
Aug 2510.65
Aug 2510.57
Aug 259.68
Jul 2510.55
Jul 2510.42
Jul 2510.38
Jul 2510.42
Jun 2510.19
Jun 259.81
Jun 259.93
Jun 2510.36
May 259.98
May 259.8
May 2510.3
May 2510.07
May 258.16
Apr 257.78
Apr 257.51
Apr 257.48
Apr 257.02
Mar 257.76
Mar 257.73
Mar 257.83
Mar 257.72
Feb 258.14
Feb 2514.33
Feb 2515.43
Feb 2515.67
Jan 2515.61
Jan 2515.45
Jan 2515.1
Jan 2514.22
Jan 2515.18
Dec 2415.18
Dec 2415.31
Dec 2416.82
Dec 2416.7
Nov 2416.74
Nov 2417.04
Nov 2415.63
Nov 2416.29
Nov 2414.44
Oct 2420.29
Oct 2420.51
Price to Book
11.522.53med 1.98Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ACA Price to Book by quarter
PeriodPrice to Book
Sep 262.39
Sep 262.39
Aug 262.39
Aug 262.38
Aug 262.39
Aug 262.38
Jul 262.7
Jul 262.7
Jul 262.7
Jul 262.7
Jul 262.7
Jun 262.69
Jun 262.53
Jun 262.41
Jun 262.28
May 262.36
May 262.25
May 262.31
May 262.42
May 262.32
Apr 262.23
Apr 262.14
Apr 262.09
Apr 262.01
Mar 261.92
Mar 261.88
Mar 261.97
Mar 262.05
Feb 262.01
Feb 262.39
Feb 262.42
Feb 262.36
Jan 262.17
Jan 262.15
Jan 262.18
Jan 262.11
Jan 262.02
Dec 252.09
Dec 252.11
Dec 252.1
Dec 252.03
Nov 252.02
Nov 251.94
Nov 251.9
Nov 251.88
Oct 251.93
Oct 251.83
Oct 251.82
Oct 251.74
Oct 251.8
Sep 251.81
Sep 251.87
Sep 251.86
Sep 251.9
Aug 251.93
Aug 251.94
Aug 251.88
Aug 251.87
Aug 251.66
Jul 251.81
Jul 251.79
Jul 251.78
Jul 251.79
Jun 251.75
Jun 251.68
Jun 251.7
Jun 251.78
May 251.71
May 251.68
May 251.77
May 251.73
May 251.69
Apr 251.61
Apr 251.55
Apr 251.55
Apr 251.45
Mar 251.6
Mar 251.6
Mar 251.62
Mar 251.6
Feb 251.68
Feb 251.86
Feb 252
Feb 252.03
Jan 252.03
Jan 252.01
Jan 251.96
Jan 251.85
Jan 251.97
Dec 241.97
Dec 241.99
Dec 242.18
Dec 242.17
Nov 242.17
Nov 242.21
Nov 242.03
Nov 242.12
Nov 241.87
Oct 241.89
Oct 241.91
Arcosa, Inc.
ACA
Stockpicker

Video analysis: ACA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ACA

Arcosa Stockholders Approve Acquisition by CRH

businesswire.com · 4 Sep 2026

Arcosa Stockholders Approve Acquisition by CRH

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that the Company's stockholders approved the acquisition by CRH (NYSE: CRH) at its special meeting on September 4, 2026. Arcosa will disclose the final, certified voting results on a Form 8-K with the U.S. Securities and Exchange Commission. As previously announced, Arcosa and CRH have entered into a merger agreement for CRH to acquire 100%.

Critical Contrast: Arcosa (NYSE:ACA) versus Lafarge (OTCMKTS:LFRGY)

defenseworld.net · 4 Sep 2026

Critical Contrast: Arcosa (NYSE:ACA) versus Lafarge (OTCMKTS:LFRGY)

Arcosa (NYSE: ACA - Get Free Report) and Lafarge (OTCMKTS:LFRGY - Get Free Report) are both materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Profitability This table compares Arcosa and Lafarge's net margins, return

Arcosa, Inc. Declares Quarterly Dividend

businesswire.com · 2 Sep 2026

Arcosa, Inc. Declares Quarterly Dividend

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.05 per share on its $0.01 par value common stock. The quarterly cash dividend is payable on October 30, 2026 to stockholders of record as of October 15, 2026. About Arcosa Arcosa, Inc. (NYSE:ACA), headquartered in Dallas, Texas, is a provider of infrastructure-r.

Deutsche Bank AG Invests $9.14 Million in Arcosa, Inc. $ACA

defenseworld.net · 24 Aug 2026

Deutsche Bank AG Invests $9.14 Million in Arcosa, Inc. $ACA

Deutsche Bank AG bought a new stake in Arcosa, Inc. (NYSE: ACA) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 62,889 shares of the company's stock, valued at approximately $9,137,000. Deutsche Bank AG owned 0.13% of Arcosa

Are UTZ, ITGR, ACA, D Obtaining Fair Deals for their Shareholders?

gurufocus.com · 17 Aug 2026

Are UTZ, ITGR, ACA, D Obtaining Fair Deals for their Shareholders?

Are UTZ, ITGR, ACA, D Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 17, 2026

Are UTZ, ITGR, ACA, D Obtaining Fair Deals for their Shareholders?

prnewswire.com · 17 Aug 2026

Are UTZ, ITGR, ACA, D Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

Arcosa Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcosa, Inc. - ACA

gurufocus.com · 17 Aug 2026

Arcosa Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcosa, Inc. - ACA

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (“KSF”) are investigating the propos

Arcosa Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcosa, Inc. - ACA

businesswire.com · 17 Aug 2026

Arcosa Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcosa, Inc. - ACA

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Arcosa, Inc. (NYSE: ACA) to CRH (NYSE: CRH). Under the terms of the proposed transaction, shareholders of Arcosa will receive $150.00 in cash for each share of Arcosa that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the con.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.